Paper36979827
Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model.
Ignacio-Mejía I and 11 others. Biomedicines, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model. Papers, record 36979827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979827
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022/048 | E022 Program of the Instituto Nacional de Pediatría | PubMed | ||
| A1-S-17090 | Fondo Sectorial de Investigación, CONACyT | PubMed | ||
| 20221351 | Instituto Politécnico Nacional | PubMed |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30037344 | Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy. | J Neuroinflammation | 2018 | https://conductscience.org/library/papers/30037344 | PubMed |
| 2 | 8660627 | The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. | Anal Biochem | 1996 | https://conductscience.org/library/papers/8660627 | PubMed |
| 3 | 29124680 | The Antiepileptic Drug Levetiracetam Protects Against Quinolinic Acid-Induced Toxicity in the Rat Striatum. | Neurotox Res | 2018 | https://conductscience.org/library/papers/29124680 | PubMed |
| 4 | 29596151 | A novel online fluorescence method for in-vivo measurement of hydrogen peroxide during oxidative stress produced in a temporal lobe epilepsy model. | Neuroreport | 2018 | https://conductscience.org/library/papers/29596151 | PubMed |
| 5 | 31356760 | Effects of Three Anti-Seizure Drugs on Cholinergic and Metabolic Activity in Experimental Status Epilepticus. | J Pharm Pharm Sci | 2019 | https://conductscience.org/library/papers/31356760 | PubMed |
| 6 | 35916986 | An aqueous extract of Syzygium cumini protects against kainate-induced status epilepticus and amnesia: evidence for antioxidant and anti-inflammatory intervention. | Metab Brain Dis | 2022 | https://conductscience.org/library/papers/35916986 | PubMed |
| 7 | 22895709 | Post-translational oxidative modification and inactivation of mitochondrial complex I in epileptogenesis. | J Neurosci | 2012 | https://conductscience.org/library/papers/22895709 | PubMed |
| 8 | 36459714 | Specific inhibition of NADPH oxidase 2 modifies chronic epilepsy. | Redox Biol | 2022 | https://conductscience.org/library/papers/36459714 | PubMed |
| 9 | 26440581 | Totarol prevents neuronal injury in vitro and ameliorates brain ischemic stroke: Potential roles of Akt activation and HO-1 induction. | Toxicol Appl Pharmacol | 2015 | https://conductscience.org/library/papers/26440581 | PubMed |
| 10 | 36600279 | Nrf2 is predominantly expressed in hippocampal neurons in a rat model of temporal lobe epilepsy. | Cell Biosci | 2023 | https://conductscience.org/library/papers/36600279 | PubMed |
| 11 | 27698937 | Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1. | Theranostics | 2016 | https://conductscience.org/library/papers/27698937 | PubMed |
| 12 | 29024726 | The antiepileptic drug levetiracetam promotes neuroblast differentiation and expression of superoxide dismutase in the mouse hippocampal dentate gyrus via PI3K/Akt signalling. | Neurosci Lett | 2018 | https://conductscience.org/library/papers/29024726 | PubMed |
| 13 | 20136375 | Levetiracetam: a comprehensive review. | Expert Rev Neurother | 2010 | https://conductscience.org/library/papers/20136375 | PubMed |
| 14 | 30622673 | Effects of Valproate Monotherapy on the Oxidant-Antioxidant Status in Mexican Epileptic Children: A Longitudinal Study. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/30622673 | PubMed |
| 15 | 23137652 | Advantages and limitations of brain imaging methods in the research of absence epilepsy in humans and animal models. | J Neurosci Methods | 2013 | https://conductscience.org/library/papers/23137652 | PubMed |
| 16 | 30026766 | Serum Total Antioxidant Capacity of Epileptic Children before and after Monotherapy with Sodium Valproate, Carbamazepine, and Phenobarbital. | Iran J Child Neurol | 2018 | https://conductscience.org/library/papers/30026766 | PubMed |
| 17 | 32430101 | Neuroprotective and anticonvulsant effects of sinomenine in kainate rat model of temporal lobe epilepsy: Involvement of oxidative stress, inflammation and pyroptosis. | J Chem Neuroanat | 2020 | https://conductscience.org/library/papers/32430101 | PubMed |
| 18 | 33149593 | LncRNA MEG3 Reduces Hippocampal Neuron Apoptosis via the PI3K/AKT/mTOR Pathway in a Rat Model of Temporal Lobe Epilepsy. | Neuropsychiatr Dis Treat | 2020 | https://conductscience.org/library/papers/33149593 | PubMed |
| 19 | 32088583 | The global burden of epilepsy report: Implications for low- and middle-income countries. | Epilepsy Behav | 2020 | https://conductscience.org/library/papers/32088583 | PubMed |
| 20 | 31302262 | Protective Role of Levetiracetam Against Cognitive Impairment And Brain White Matter Damage in Mouse prolonged Cerebral Hypoperfusion. | Neuroscience | 2019 | https://conductscience.org/library/papers/31302262 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794835 | Levetiracetam and Peripheral Oxidative Stress Biomarkers in Epilepsy: A Systematic Review of Human Evidence. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794835 | PubMed |
| 42589265 | Anti-Inflammatory and Antioxidant Strategies in Epilepsy: From Molecular Mechanisms to Threshold Management. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589265 | PubMed |
| 42571206 | Suspected levetiracetam drug-induced lupus in a child: A case report. | SAGE Open Med Case Rep | 2026 | https://conductscience.org/library/papers/42571206 | PubMed |
| 40217882 | MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40217882 | PubMed |
| 39996118 | Mimosa pudica L. aqueous extract protects mice against pilocarpine-picrotoxin kindling-induced temporal lobe epilepsy, oxidative stress, and alteration in GABAergic/cholinergic pathways and BDNF expression. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39996118 | PubMed |
| 39695322 | Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/39695322 | PubMed |
| 39334752 | 10-Gingerol Increases Antioxidant Enzymes and Attenuates Lipopolysaccharide-Induced Inflammation by Modulating Adipokines in 3T3-L1 Adipocytes. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39334752 | PubMed |
| 39273262 | Effect of Levetiracetam on Oxidant-Antioxidant Activity during Long-Term Temporal Lobe Epilepsy in Rats. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273262 | PubMed |
| 38530519 | Therapeutic Effect of Levetiracetam Against Thioacetamide-Induced Hepatic Encephalopathy Through Inhibition of Oxidative Stress and Downregulation of NF-κB, NLRP3, iNOS/NO, Pro-Inflammatory Cytokines and Apoptosis. | Inflammation | 2024 | https://conductscience.org/library/papers/38530519 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 | NCBI Gene |
| GSR | 2936 | PubTator's text mining | https://conductscience.org/library/genes/2936 | NCBI Gene |
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
| SV2A | 9900 | PubTator's text mining | https://conductscience.org/library/genes/9900 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979827
GET https://conductscience.org/api/papers/v1/36979827/references?page=2